aplomb 发表于 2025-3-23 10:35:02

Submitted on: 25 March 2016.
Revised on: 01 June 2016.
Accepted on: 01 July 2016.

___________________BIOPHARM INTERNATIONAL---ADVANSTAR COMMUNICATIONS INC

dendrites 发表于 2025-3-23 14:54:46

Submitted on: 28 April 2018.
Revised on: 06 June 2018.
Accepted on: 07 July 2018.

___________________BIOPHARM INTERNATIONAL---ADVANSTAR COMMUNICATIONS INC

Negligible 发表于 2025-3-23 19:11:31

Submitted on: 04 June 1998.
Revised on: 24 September 1998.
Accepted on: 29 October 1998.

___________________BIOPHARM INTERNATIONAL---ADVANSTAR COMMUNICATIONS INC

Locale 发表于 2025-3-24 00:03:34

Submitted on: 06 April 2000.
Revised on: 27 June 2000.
Accepted on: 04 August 2000.

___________________BIOPHARM INTERNATIONAL---ADVANSTAR COMMUNICATIONS INC

充满人 发表于 2025-3-24 04:55:42

http://reply.papertrans.cn/1/38/3721/3721-15.png

格子架 发表于 2025-3-24 09:13:09

Submitted on: 01 December 2001.
Revised on: 17 February 2002.
Accepted on: 16 March 2002.

___________________BIOPHARM INTERNATIONAL---ADVANSTAR COMMUNICATIONS INC

晚来的提名 发表于 2025-3-24 12:14:06

Submitted on: 18 September 2014.
Revised on: 09 December 2014.
Accepted on: 06 February 2015.

___________________BIOPHARM INTERNATIONAL---ADVANSTAR COMMUNICATIONS INC

prediabetes 发表于 2025-3-24 15:13:14

http://reply.papertrans.cn/1/38/3721/3721-18.png

eulogize 发表于 2025-3-24 21:35:53

http://reply.papertrans.cn/1/38/3721/3721-19.png

GET 发表于 2025-3-25 00:13:46

Submitted on: 15 December 2015.
Revised on: 16 March 2016.
Accepted on: 07 April 2016.

___________________BIOPHARM INTERNATIONAL---ADVANSTAR COMMUNICATIONS INC
页: 1 [2] 3 4
查看完整版本: SCIE期刊BIOPHARM INTERNATIONAL 2024/2025影响因子:0.114 (BIOPHARM INT) (1542-166X). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science C